DC Bead™ Clinical Bibliography

March 2007 – December 2018
106 Publications
6301 Patients*

Drug-Eluting Bead: DEBDOX™

DC Bead™  with doxorubicin for the local treatment of tumours in patients with hepatocellular carcinoma

Download PDF
*Important note regarding patient numbers. Please note that patient numbers in red were not counted toward the total number of patients given above. Patient numbers in green reflect the numbers counted in the total, which were potentially duplicated by the numbers in red. Numbers in black were not considered to have potential duplications and were included in the total number above.
Publication title: Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Authors Liu YS, Lin CY, Chuang MT, et al.
Journal BMC Gastroenterol
Patients 72
Date published August 2018
Impact factor 2.731
Publication title: Safety of Drug-Eluting-Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunt
Authors Rief K, Pirasteh A, Shenoy-Bhangl A, et al.
Journal J Clin Interv Radiol ISVIR
Patients 10
Date published June 2018
Impact factor Unknown
Publication title: Outpatient transarterial chemoembolization of hepatocellular carcinoma: Review of a same-day discharge strategy
Authors Fritsche MR, Watchmaker JM, Lipnik AJ, et al
Journal J Vasc Interv Radiol
Patients 193
Date published March 2018
Impact factor 2.758
Publication title: Assessment of response to transcatheter arterial chemoembolization with doxorubicin-eluting microspheres: Tumor biology and hepatocellular carcinoma recurrence in a 5-year transplant cohort
Authors Sandow TA, Arndt SE, Albar AA, et al.
Journal Radiology
Patients 93
Date published March 2018
Impact factor 7.469
Publication title: Transarterial chemoembolization with small drug-eluting beads in patients with hepatocellular carcinoma: Experience from a cohort of 421 patients at an Italian center
Authors Aliberti C, Carandina R, Lonardi S, et al.
Journal J Vasc Interv Radiol
Patients 421
Date published November 2017
Impact factor 2.758
Publication title: Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug TACE using doxorubicin-eluting beads: Long-term survival in 313 patients
Authors Gomes AS, Monteleone PA, Sayre JW, et al.
Journal Am J Roentgenol
Patients 313
Date published October 2017
Impact factor 3.125
Publication title: Korean multicenter registry of transcatheter arterial chemoembolization with drug-eluting embolic agents for nodular hepatocellular carcinomas: Six-month outcome analysis
Authors Lee M, Chung JW, Lee K-H, et al.
Journal J Vasc Interv Radiol
Patients 152
Date published April 2017
Impact factor 2.758
Publication title: Acute pancreatitis as a complication of trans-arterial chemoembolization of hepatocellular cancer-case report and review of literature
Authors KrishnamurthyP, Brown M, Agrawal S, et al.
Journal J Gastrointest Oncol
Patients 1
Date published February 2017
Impact factor Unknown
Publication title: Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size
Authors Lee YK, Jung KS, Kim DY, et al.
Journal J Gastroenterol Hepatol
Patients 106
Date published February 2017
Impact factor 3.483
Publication title: In vivo drug delivery performance of lipiodol-based emulsion or drug-eluting beads in patients with hepatocellular carcinoma
Authors Lilienberg E, Dubbelboer IR, Karalli A, et al.
Journal Mol Pharm
Patients 12
Date published February 2017
Impact factor 4.556
Publication title: DEB-TACE for intermediate and advanced HCC – Initial experience in a Brazilian cancer center
Authors Luz JHM, Luz PM, Martin HS, et al.
Journal Cancer Imaging
Patients 21
Date published February 2017
Impact factor 3.016
Publication title: Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma
Authors Taussig MD, Koran ME, Mouli SK, et al.
Journal HPB (Oxford)
Patients 53
Date published February 2017
Impact factor 3.131
Publication title: Safety and efficacy of doxorubicin drug-eluting embolic chemoembolization of hepatocellular carcinoma supplied by extrahepatic collateral arteries
Authors Lokken RP, Fidelman N, Kolli KP, et al.
Journal J Vasc Interv Radiol
Patients 16
Date published November 2016
Impact factor 2.758
Publication title: Benefit of patients with an early and progressed state of hepatocellular carcinoma treated with drug-eluting beads
Authors Rathmann N, Sadick M, Rathmann B, et al
Journal In Vivo
Patients 46
Date published September 2016
Impact factor 1.116
Publication title: Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
Authors Monier A, Guiu B, Duran R, et al.
Journal Eur Radiol
Patients 57
Date published July 2016
Impact factor 4.027
Publication title: Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone
Authors Brown KT, Do RK, Gonen M, et al.
Journal J Clin Oncol
Patients 50
Date published June 2016
Impact factor 26.303
Publication title: Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization
Authors Gorodetski B., Chapiro J., Schernthaner R., et al.
Journal Eur Radiol
Patients 38
Date published June 2016
Impact factor 4.027
Publication title: Drug-eluting bead transarterial chemoembolization as bridge therapy for hepatocellular carcinoma before living-donor liver transplantation
Authors Yu CY, Ou HY, Went CC, et al.
Journal Transplant Proc
Patients 60
Date published May 2016
Impact factor 0.806
Publication title: Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
Authors Facciourusso A, Mariani L, Sposito C, et al.
Journal J Gastroenterol Hepatol
Patients 145
Date published March 2016
Impact factor 3.483
Publication title: Survival in unresectable AJCC stage I and II HCC and the effect of DEB-TACE: SEER versus tertiary cancer center cohort study
Authors Xing M, Kokabi N, Prajapati HJ, et al.
Journal J Comp Eff Res
Patients 137
Date published March 2016
Impact factor 1.906
Publication title: Superselective chemoembolization of HCC: Comparison of short-term safety and efficacy between drug-eluting LC Beads, QuadraSpheres, and conventional ethiodized oil emulsion
Authors Duan F, Wang EQ, Lam MG, et al.
Journal Radiology
Patients 47
Date published February 2016
Impact factor 7.469
Publication title: Radioembolization versus chemoembolization (DEBDOX) for the treatment of unresectable hepatocellular carcinoma: A propensity matched study
Authors Akinwande O, Phillips P, Scoggins C, and Martin RC.
Journal Anticancer Res
Patients 291
Date published January 2016
Impact factor 1.865
Publication title: Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead chemoembolization
Authors Kokabi N, Ludwig JM, Camacho JC, et al.
Journal J Vasc Interv Radiol
Patients 57
Date published December 2015
Impact factor 2.758
Publication title: Immediate post-doxorubicin drug-eluting beads chemoembolization MR apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study
Authors Kokabi N, Camacho JC, Xing M, et al.
Journal J Magn Reson Imaging
Patients 12 (not included in total count; known or potential duplication with Kokabi et al. JVIR 2015)
Date published October 2015
Impact factor 3.612
Publication title: Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
Authors Vesselle G, Quirier-Leleu C, Velasco S, et al.
Journal Eur Radiol
Patients 172
Date published October 2015
Impact factor 4.027
Publication title: Doxorubicin‑loaded drug‑eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
Authors Arabi M, Benmousa A, Bzeizi K, et al.
Journal Saudi J Gastroenterol
Patients 35
Date published June 2015
Impact factor 1.520
Publication title: Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Authors Kloeckner R, Weinmann A, Prinz F, et al.
Journal BMC Cancer
Patients 76
Date published June 2015
Impact factor 3.288
Publication title: Drug-eluting beads loaded with doxorubicin (DEBDOX) chemoembolisation before liver transplantation for hepatocellular carcinoma: An imaging/histologic correlation study
Authors Pauwels X, Azahaf M, Lassailly G, et al.
Journal Cardiovasc Intervent Radiol
Patients 28
Date published June 2015
Impact factor 2.210
Publication title: Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma
Authors Pitton MB, Kloeckner R, Ruckes C, et al.
Journal Cardiovasc Intervent Radiol
Patients 12 (not included in total count; known or potential duplication with Kloeckner et al BMC Cancer 2015)
Date published April 2015
Impact factor 2.210
Publication title: Safety and efficacy of 70–150 μm and 100–300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma
Authors Deipolyi AR, Oklu R, Al-Ansari S, et al.
Journal J Vasc Interv Radiol
Patients 84
Date published February 2015
Impact factor 2.758
Publication title: Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma
Authors Liu YS, Ou MC, Tsai YS, et al.
Journal Korean J Radio
Patients 53 (not included in total count; known or potential duplication with Liu et al BMC Gastroenterol 2018)
Date published February 2015
Impact factor 3.072
Publication title: Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization
Authors Ray CE, Brown AC, Green TJ, et al.
Journal Am J Roentgenol
Patients 43
Date published February 2015
Impact factor 3.125
Publication title: Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: radiological outcomes and safety profile
Authors Spreafico C, Cascella T, Facciorusso A, et al.
Journal Cardiovasc Intervent Radiol
Patients 45
Date published February 2015
Impact factor 2.210
Publication title: Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma
Authors Vadot L, Boulin M, Guiu B, et al.
Journal J Clin Pharm Ther
Patients 35 (not included in total count; known or potential duplication with Boulin et al. DLD 2014)
Date published February 2015
Impact factor 1.661
Publication title: Preservation of quality of life with doxorubicin drug eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study
Authors Xing M, Webber G, Prajapati HJ, et al.
Journal J Gastroenterol Hepatol
Patients 118 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published February 2015
Impact factor 3.483
Publication title: The efficiency of transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
Authors Kucukkapan A and Karakose S
Journal Eur J Gen Med
Patients 26
Date published January 2015
Impact factor Unknown
Publication title: Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC
Authors Prajapati HJ, Xing M, Spivey JR, et al.
Journal Am J Roentgenol
Patients 94 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published December 2014
Impact factor 3.125
Publication title: Pilot study evaluating catheter-directed contrast-enhanced ultrasound compared to catheter-directed computed tomography arteriography as adjuncts to digital subtraction angiography to guide transarterial chemoembolization
Authors Burgmans MC, van Erkel AR, Too CW, et al.
Journal Clin Radiol
Patients 9
Date published October 2014
Impact factor 2.282
Publication title: Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response
Authors Frenette CT, Osorio RC, Stark J, et al.
Journal Transplantation
Patients 35
Date published October 2014
Impact factor 3.960
Publication title: Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization
Authors Odisio BC, Galastri F, Avritscher R, et al.
Journal Cardiovasc Intervent Radiol
Patients 23
Date published August 2014
Impact factor 2.210
Publication title: Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center
Authors Andersen KJ, Grønbaek H, Villadsen GE, et al.
Journal Indian J Gastroenterol
Patients 30
Date published July 2014
Impact factor Unknown
Publication title: Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
Authors Golfieri R, Giampalma E, Renzulli M, et al.
Journal Br J Cancer
Patients 89
Date published July 2014
Impact factor 5.922
Publication title: Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program
Authors Nasser F, Cavalcante RN, Galastri FL, et al
Journal J Vasc Interv Radiol
Patients 154
Date published July 2014
Impact factor 2.758
Publication title: Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads
Authors Yeo DM, Choi JI, Lee YJ, et al.
Journal J Comput Assist Tomogr
Patients 76
Date published May 2014
Impact factor 1.292
Publication title: Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma
Authors Boulin M, Adam H, Guiu B, et al.
Journal Dig Liver Dis
Patients 52
Date published April 2014
Impact factor 3.287
Publication title: Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma
Authors Kalva SP, Pectasides M, Liu R, et al.
Journal Cardiovasc Intervent Radiol
Patients 80 (not included in total count; known or potential duplication with Kalva et al. JVIR 2013)
Date published April 2014
Impact factor 2.210
Publication title: Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma
Authors Muros-Ortega M, Díaz-Carrasco MS, Capel A, et al.
Journal Int J Clin Pharm
Patients 53
Date published December 2013
Impact factor 1.508
Publication title: Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization
Authors Green TJ, Rochon PJ, Chang S, et al.
Journal J Vasc Interv Radiol
Patients 22 (21 patients counted due to potential overlap of one Child Pugh C patient with Ray et al. AJR 2015)
Date published November 2013
Impact factor 2.758
Publication title: Long-term recurrence analysis post drug eluting bead (DEB) chemoembolization for hepatocellular carcinoma (HCC)
Authors Malagari K, Pomoni M, Sotirchos VS, et al.
Journal Hepato-Gastroenterology
Patients 45 (not included in total count; known or potential duplication with Malagari et al. CVIR 2012)
Date published September 2013
Impact factor Unknown
Publication title: Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
Authors Nicolini D, Svegliati-Baroni G, Candelari R, et al.
Journal World J Gastroenterol
Patients 22
Date published September 2013
Impact factor 3.300
Publication title: Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment
Authors Boatta E, Corona M, Cannavale A, et al.
Journal Indian J Radiol Imaging
Patients 154
Date published May 2013
Impact factor Unknown
Publication title: Multivariate analysis of prognostic factors for survival following doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma
Authors Sellers MT, Huggins S, Kegley K, et al.
Journal J Vasc Interv Radiol
Patients 168
Date published May 2013
Impact factor 2.758
Publication title: Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response
Authors Oh JS, Chun HJ, Choi BG, et al.
Journal J Vasc Interv Radiol
Patients 90
Date published April 2013
Impact factor 2.758
Publication title: mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
Authors Prajapati HJ, Spivey JR, Hanish SI, et al.
Journal Ann Oncol
Patients 120 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published April 2013
Impact factor 13.926
Publication title: Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: Possible predictive role of response to treatment
Authors Goffredo V, Gadaleta CD, Laterza A, et al.
Journal Mol Clin Oncol
Patients 30
Date published March 2013
Impact factor Unknown
Publication title: Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: Comparison of small-versus medium-size particles
Authors Padia SA, Shivaram G, Bastawrous S, et al.
Journal J Vasc Interv Radiol
Patients 61
Date published March 2013
Impact factor 2.758
Publication title: Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma
Authors Prajapati HJ, Dhanasekaran R, El-Rayes BF, et al.
Journal J Vasc Interv Radiol
Patients 121
Date published March 2013
Impact factor 2.758
Publication title: Factors affecting survival following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma
Authors Kalva SP, Pectasides M, Yeddula K, et al.
Journal J Vasc Interv Radiol
Patients 130
Date published February 2013
Impact factor 2.758
Publication title: Intraprocedural C-arm dual-phase cone-beam CT: Can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
Authors Loffroy R, De Lin M, Yenokyan G, et al.
Journal Radiology
Patients 27
Date published February 2013
Impact factor 7.469
Publication title: Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma
Authors Petruzzi NJ, Frangos AJ, Fenkel JM, et al.
Journal J Vasc Interv Radiol
Patients 33
Date published February 2013
Impact factor 2.758
Publication title: DC Bead transarterial chemoembolization is effective in hepatocellular carcinoma refractory to conventional transarterial chemoembolization: A pilot study
Authors Song DS, Choi JY, Yoo SH, et al.
Journal Gut Liver
Patients 10 (not included in total count; known or potential duplication with Song et al. J Hepatol 2012)
Date published January 2013
Impact factor 2.849
Publication title: Quantitative and volumetric European association for the study of the liver and response evaluation criteria in solid tumors measurements: Feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization
Authors Lin M, Pellerin O, Bhagat N, et al.
Journal J Vasc Interv Radiol
Patients 17
Date published December 2012
Impact factor 2.758
Publication title: Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC)
Authors SkowaschM, Schneider J, Otto G, et al.
Journal Eur J Radiol
Patients 50
Date published December 2012
Impact factor 2.843
Publication title: Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
Authors Song MJ, Chun HJ, Song do S, et al.
Journal J Hepatol
Patients 60
Date published December 2012
Impact factor 14.911
Publication title: Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: Five-year survival analysis
Authors Malagari K, Pomoni M, Moschouris H, et al.
Journal Cardiovasc Intervent Radiol
Patients 173 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published October 2012
Impact factor 2.210
Publication title: Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization
Authors Prajapati HJ, Rafi S, El-Rayes BF, et al.
Journal J Vasc Interv Radiol
Patients 76 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published October 2012
Impact factor 2.758
Publication title: Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads
Authors Golowa YS, Cynamon J, Reinus JF, et al.
Journal J Vasc Interv Radiol
Patients 85
Date published August 2012
Impact factor 2.758
Publication title: Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design
Authors Burrel M, Reig M, Forner A, et al.
Journal J Hepatol
Patients 104
Date published June 2012
Impact factor 14.911
Publication title: Post embolization syndrome in doxorubicin eluting chemoembolization with DC Bead
Authors Pomoni M, Malagari K, Moschouris H, et al.
Journal Hepatogastroenterology
Patients 237 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published May 2012
Impact factor Unknown
Publication title: Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol
Authors Recchia F, Passalacqua G, Filauri P, et al.
Journal Oncol Rep
Patients 35
Date published May 2012
Impact factor 2.976
Publication title: Management of diffuse hepatocellular carcinoma (≥ 10 lesions) with doxorubicin-loaded DC Beads is a safe and effective treatment option
Authors Cannon RM, Urbano J, Kralj I, et al.
Journal Onkologie
Patients 176
Date published April 2012
Impact factor Unknown
Publication title: Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads
Authors Guiu B, Deschamps F, Aho S, et al.
Journal J Hepatol
Patients 50 (not included in total count; known or potential duplication with Monier et al. Eur Radiol 2016)
Date published March 2012
Impact factor 14.911
Publication title: Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy
Authors Farris AB 3rd, Dursun N, Dhanasekaran R, et al.
Journal Pathol Res Pract
Patients 17 (not included in total count; known or potential duplication with Prajapti et al. JVIR 2013)
Date published January 2012
Impact factor 1.466
Publication title: Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants
Authors Namur J, Citron SJ, Sellers MT, et al.
Journal J Hepatol
Patients 6 (not included in total count; known or potential duplication with Sellers et al. JVIR 2013)
Date published December 2011
Impact factor 14.911
Publication title: Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma
Authors Sacco R, Bargellini I, Bertini M, et al.
Journal J Vasc Interv Radiol
Patients 33
Date published November 2011
Impact factor 2.758
Publication title: Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: A multi-institutional registry
Authors Martin RC 2nd, Rustein L, Pérez Enguix D, et al.
Journal J Am Coll Surg
Patients 118 (not included in total count; known or potential duplication with Martin et al. Korean J Hepatol 2011)
Date published October 2011
Impact factor 4.767
Publication title: Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial
Authors Vogl TJ, Lammer J, Lencioni R, et al.
Journal Am J Roentgenol
Patients 102 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published October 2011
Impact factor 3.125
Publication title: Safety profile of sequential transcatheter chemoembolization with DC Bead™: Results of 237 hepatocellular carcinoma (HCC) patients
Authors Malagari K, Pomoni M, Spyridopoulos TN, et al.
Journal Cardiovasc Intervent Radiol
Patients 237
Date published August 2011
Impact factor 2.210
Publication title: Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: A case-control study of Asian patients
Authors Song MJ, Park CH, Kim JD, et al.
Journal Eur J Gastroenterol Hepatol
Patients 20 (not included in total count; known or potential duplication with Song et al. J Hepatol 2012)
Date published June 2011
Impact factor 2.014
Publication title: Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma
Authors Puchol F, la Parra C, Esteban E, et al.
Journal Radiologia
Patients 47
Date published May 2011
Impact factor Unknown
Publication title: Optimal technique and response of doxorubicin beads in hepatocellular cancer: Bead size and dose
Authors Martin R, Irurzun J, Munchart J, et al.
Journal Korean J Hepatol
Patients 206
Date published March 2011
Impact factor Unknown
Publication title: Transarterial chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma
Authors Kalva SP, Iqbal SI, Yeddula K, et al.
Journal Gastrointest Cancer Res
Patients 54 (not included in total count; known or potential duplication with Kalva et al. JVIR 2013)
Date published January 2011
Impact factor Unknown
Publication title: Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intra-arterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): Preliminary data
Authors Uller W, Wiggermann P, Gössmann H, et al.
Journal Clin Hemorheol Microcirc
Patients 11
Date published January 2011
Impact factor 1.914
Publication title: Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads
Authors Moschouris H, Malagari K, Kornezos I, et al.
Journal Cardiovasc Intervent Radiol
Patients 16 tumours (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published December 2010
Impact factor 2.210
Publication title: Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads : A pilot study focused on sustained tumor necrosis
Authors Moschouris H, Malagari K, Papadaki MG, et al.
Journal Cardiovasc Intervent Radiol
Patients 10 (not included in total count; known or potential duplication with Malagari et al. CVIR. 2011)
Date published October 2010
Impact factor 2.210
Publication title: Chemoembolization follow-up of hepatocellular carcinoma with MR imaging; usefulness of evaluating enhancement features on one-month posttherapy MR imaging for predicting residual disease
Authors Kalb B, Chamsuddin A, Nazzal L, et al.
Journal J Vasc Interv Radiol
Patients 21
Date published September 2010
Impact factor 2.758
Publication title: The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan Criteria in patients with hepatocellular carcinoma
Authors Dhanasekaran R, Khanna V, Kooby DA, et al.
Journal J Vasc Interv Radiol
Patients 44 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published August 2010
Impact factor 2.758
Publication title: MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma
Authors Kloeckner R, Otto G, Biesterfeld S, et al.
Journal Cardiovasc Intervent Radiol
Patients 20 ( not included in total count; known or potential duplication with Kloeckner et al. BMC Cancer 2015)
Date published June 2010
Impact factor 2.210
Publication title: Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with Bead Block for hepatocellular carcinoma
Authors Malagari K, Pomoni M, Kelekis A, et al.
Journal Cardiovasc Intervent Radiol
Patients 41 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published June 2010
Impact factor 2.210
Publication title: Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC)
Authors Dhanasekaran R, Kooby DA, Staley CA, et al.
Journal J Surg Oncol
Patients 45 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published May 2010
Impact factor 2.886
Publication title: Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: A preliminary study
Authors Dhanasekaran R,Kooby DA, Staley CA, et al.
Journal HPB (Oxford)
Patients 50 (not included in total count; known or potential duplication with Prajapati et al. JVIR 2013)
Date published April 2010
Impact factor 3.131
Publication title: Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study
Authors Lammer J, Malagari K, Vogl T, et al
Journal Cardiovasc Intervent Radiol
Patients 93 (not included in total patient count due to potential duplication with eg Malagari et al CVIR 2011)
Date published February 2010
Impact factor 2.210
Publication title: Application of DC beads in hepatocellular carcinoma: Clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization
Authors Sadick M, Haas S, Loehr M, et al.
Journal Onkologie
Patients 24
Date published February 2010
Impact factor Unknown
Publication title: Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: Single centre early experience
Authors Nawawi O, Hazman M, Abdullah B, et al.
Journal Biomed Imaging Interv J
Patients 19
Date published January 2010
Impact factor Unknown
Publication title: Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the United States
Authors Reyes DK, Vossen JA, Kamel IR, et al.
Journal Cancer J
Patients 20
Date published November 2009
Impact factor 3.519
Publication title: Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: Midterm results of doxorubicin-loaded DC Bead
Authors Malagari K, Alexopoulou E, Chatzimichail K, et al.
Journal Abdom Imaging
Patients 71 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published September 2008
Impact factor 2.443
Publication title: Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients
Authors Malagari K, Chatzimichael K, Alexopoulou E, et al.
Journal Cardiovasc Intervent Radiol
Patients 62 (not included in total count; known or potential duplication with Malagari et al. CVIR 2011)
Date published March 2008
Impact factor 2.210
Publication title: A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead
Authors Poon RTP, Tso WK, Pang RWC, et al
Journal Clin Gastroenterol Hepatol
Patients 35
Date published September 2007
Impact factor 7.683
Publication title: Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
Authors Varela M, Real M, Burrel M, et al
Journal J Hepatol
Patients 27 (not included in total patient count due to potential duplication with Burrel et al J Hepatol 2012)
Date published March 2007
Impact factor 14.911

Combination Therapywith DEBDOX™

Publication title: Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma
Authors Buckstein M, Kim E, Fischman A, et al.
Journal J Gastrointest Oncol
Patients 103
Date published August 2018
Impact factor Unknown
Publication title: Sorafenib in combination with transarterial chemoembolization in patients with unrespectable hepatocellular carcinoma (TACE2): A randomized placebo-controlled, double blind, phase 3 trial
Authors Meyer T, Fox R, Ma YT, et al.
Journal Lancet Gastroenterol Hepatol
Patients 313
Date published August 2017
Impact factor Unknown
Publication title: Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Authors Lencioni R, Llovet JM, Han G, et al.
Journal J Hepatol
Patients 304
Date published May 2016
Impact factor 14.911
Publication title: Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib
Authors Corona-Villalobos CP, Halappa VG, Geschwind JF, et al.
Journal Eur Radiol
Patients 41
Date published February 2014
Impact factor 4.027
Publication title: The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
Authors Cabrera R, Pannu DS, Caridi J, et al.
Journal Aliment Pharmacol Ther
Patients 47
Date published July 2011
Impact factor 7.357
Publication title: Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
Authors Pawlik TM, Reyes DK, Cosgrove D, et al.
Journal J Clin Oncol
Patients 35
Date published October 2011
Impact factor 26.303

The literature references provided in this bibliography were evaluated for safety and performance, as well as state of the art application. Case reports are included if a specific safety issue was reported. Literature reporting the concomitant use of doxorubicin loaded DC Bead™ with other therapies appear in the Combination Therapy section.

Note regarding the impact factor of each journal:
The impact factors were obtained from the Research Gate website on 05-December-2018, https://www.researchgate.net/publication/326016068_2018_Journal_Impact_Factor_2018/download. The downloaded pdf was entitled: “2018JournalImpactFactor.” Impact factors noted as ‘unknown’ were not found in the 2018 Journal Impact Factor document.

Bibliography